We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

86 hedge funds and large institutions have $85M invested in Xeris Biopharma Holdings in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

150% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 14

86% more capital invested

Capital invested by funds: $45.8M → $85M (+$39.3M)

28% more funds holding

Funds holding: 67 → 86 (+19)

22.83% more ownership

Funds ownership: 62.51% → 85.34% (+23%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $685K

Holders
86
Holders Change
+19
Holders Change %
+28.36%
% of All Funds
1.76%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
35
Reduced
14
Closed
10
Calls
–
Puts
$685K
Net Calls
-$685K
Net Calls Change
-$684K

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$9.22M
2
SM
Sabby Management
Florida
+$3.78M
3
Invesco
Invesco
Georgia
+$3.48M
4
SC
Sessa Capital
New York
+$3.27M
5
Millennium Management
Millennium Management
New York
+$1.76M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$1.95M
2
HP
Hound Partners
New York
-$1.64M
3
Renaissance Technologies
Renaissance Technologies
New York
-$984K
4
DM
Deerfield Management
New York
-$887K
5
Blackstone Inc
Blackstone Inc
New York
-$762K
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Soros Fund Management
New York
$532K +$696K +200,000 New
MCM
27
Moore Capital Management
New York
$466K – – –
BCM
28
BlueCrest Capital Management
Jersey
$438K +$573K +164,700 New
IWM
29
IHT Wealth Management
Illinois
$432K +$94.2K +27,050 +20%
N
30
Nuveen
North Carolina
$430K -$50.8K -14,592 -8%
Goldman Sachs
31
Goldman Sachs
New York
$427K +$136K +39,073 +32%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$377K -$2.77K -796 -0.6%
Two Sigma Investments
33
Two Sigma Investments
New York
$317K -$207K -59,579 -33%
Renaissance Technologies
34
Renaissance Technologies
New York
$279K -$984K -282,516 -73%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$273K +$9.95K +2,858 +3%
Charles Schwab
36
Charles Schwab
California
$247K +$15.4K +4,432 +5%
Commonwealth Equity Services
37
Commonwealth Equity Services
Massachusetts
$244K +$285K +81,934 +819%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$201K +$114K +32,800 +77%
HP
39
Hound Partners
New York
$181K -$1.64M -469,667 -87%
BBVA
40
Banco Bilbao Vizcaya Argentaria
Spain
$163K +$214K +61,542 New
Two Sigma Advisers
41
Two Sigma Advisers
New York
$155K +$89.8K +25,800 +79%
SC
42
Searle & Co
Connecticut
$148K +$59.2K +17,000 +33%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$144K – – –
Jacobs Levy Equity Management
44
Jacobs Levy Equity Management
New Jersey
$142K -$81.2K -23,317 -30%
Squarepoint
45
Squarepoint
New York
$122K +$101K +28,973 +172%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$121K +$49.7K +14,269 +46%
Morgan Stanley
47
Morgan Stanley
New York
$114K +$138K +39,748 +1,260%
Arrowstreet Capital
48
Arrowstreet Capital
Massachusetts
$112K +$146K +42,000 New
Wells Fargo
49
Wells Fargo
California
$93K +$34.2K +9,816 +39%
AllianceBernstein
50
AllianceBernstein
Tennessee
$93K +$50.8K +14,600 +71%
1
2
3 4

XERS Hedge Fund Activity: Q2 2020 in Review

86 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q2 2020, worth a combined $85M — up 86% from $45.8M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XERS positions and 10 closed out — a net gain of 19 holders — while 35 added to existing stakes and 14 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $9.22M. The largest seller was Redmile Group, cutting an estimated $1.95M.

  • 86 institutional investors held Xeris Biopharma Holdings (XERS) as of Q2 2020, up from 67 in Q1 2020.
  • Funds reported $85M of Xeris Biopharma Holdings stock for Q2 2020, up 86% quarter-over-quarter.
  • 29 funds opened new Xeris Biopharma Holdings positions in Q2 2020 and 10 closed out, a net change of +19 holders.
  • The largest Xeris Biopharma Holdings buyer in Q2 2020 was JP Morgan Chase, an estimated $9.22M added.
  • The largest Xeris Biopharma Holdings seller in Q2 2020 was Redmile Group, an estimated $1.95M sold.

Based on aggregated 13F filings for Q2 2020.